Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sahastara-remedy Extract Capsule in Exercise-induced Muscle Damage
TCTR20250820006Phase 2Not yet recruiting
- Sponsor
- National Science, Research and Innovation Fund
- Start
- Oct 2025
- Countries
- 1
01
Overview
Phase 2 trial in exercise-induced muscle damage (EIMD), sponsored by National Science, Research and Innovation Fund. Planned start Oct 2025; status: not yet recruiting.
02
Conditions
exercise-induced muscle damage (EIMD)
Beyond the preview
Go deeper on TCTR20250820006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250820006.